Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching.
HAIC
TACE
advance-stage
lenvatinib
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
05 Sep 2023
05 Sep 2023
Historique:
received:
25
07
2023
revised:
04
09
2023
accepted:
04
09
2023
medline:
29
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
This study aimed to evaluate the effect of lenvatinib (LEN) combined with transcatheter intra-arterial therapy (TIT) for advanced-stage hepatocellular carcinoma (HCC) after propensity score matching (PSM). This retrospective study enrolled 115 patients with advanced-stage HCC who received LEN treatment. The patients were categorized into the LEN combined with TIT group (
Identifiants
pubmed: 37762018
pii: ijms241813715
doi: 10.3390/ijms241813715
pmc: PMC10530984
pii:
doi:
Substances chimiques
lenvatinib
EE083865G2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Drugs Real World Outcomes. 2021 Sep;8(3):301-314
pubmed: 33792850
Front Pharmacol. 2021 Oct 01;12:744578
pubmed: 34658879
Dig Dis. 2011;29(3):333-8
pubmed: 21829026
Cancer Commun (Lond). 2023 Apr;43(4):415-434
pubmed: 36825684
Lancet. 2018 Mar 24;391(10126):1163-1173
pubmed: 29433850
J Hepatol. 2022 Mar;76(3):681-693
pubmed: 34801630
Med Oncol. 2021 Apr 21;38(6):60
pubmed: 33881631
Cancers (Basel). 2020 Apr 19;12(4):
pubmed: 32325921
Liver Int. 2019 Dec;39(12):2214-2229
pubmed: 31436873
Cancer Med. 2023 Jun;12(11):12325-12335
pubmed: 37062077
Protein Cell. 2011 Apr;2(4):266-72
pubmed: 21533771
Am J Gastroenterol. 2008 Apr;103(4):914-21
pubmed: 18177453
Target Oncol. 2022 Nov;17(6):643-653
pubmed: 36272060
Can J Gastroenterol Hepatol. 2018 Jun 3;2018:4756147
pubmed: 29974040
World J Gastroenterol. 2015 Mar 28;21(12):3462-71
pubmed: 25834310
Signal Transduct Target Ther. 2021 Feb 15;6(1):62
pubmed: 33589595
Cancer. 2021 Oct 15;127(20):3782-3793
pubmed: 34237154
Oncol Lett. 2020 Apr;19(4):2667-2676
pubmed: 32218817
Liver Cancer. 2020 Dec;9(6):756-770
pubmed: 33442544
Geriatr Nurs. 2023 Jul-Aug;52:115-120
pubmed: 37290216
J Hepatol. 2022 Feb;76(2):353-363
pubmed: 34648895
Mol Clin Oncol. 2014 May;2(3):393-398
pubmed: 24772306
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Eur Surg Res. 2023;64(2):268-277
pubmed: 36812900
J Gastroenterol Hepatol. 2023 Apr;38(4):486-495
pubmed: 36516040
Nature. 2011 May 19;473(7347):298-307
pubmed: 21593862
J Gastroenterol Hepatol. 2023 Jul;38(7):1140-1147
pubmed: 36880677
Liver Cancer. 2020 Sep;9(5):583-595
pubmed: 33083282
Semin Liver Dis. 2010 Feb;30(1):52-60
pubmed: 20175033
Front Oncol. 2023 May 03;13:1178428
pubmed: 37207144
Cancer. 2011 Oct 1;117(19):4475-83
pubmed: 21437884
Hepatology. 2000 Dec;32(6):1224-9
pubmed: 11093728
Hepatol Commun. 2022 Jul;6(7):1786-1802
pubmed: 35238496
Cancers (Basel). 2023 Mar 16;15(6):
pubmed: 36980684
Liver Cancer. 2020 Jun;9(3):245-260
pubmed: 32647629
Actas Dermosifiliogr (Engl Ed). 2021 Jan;112(1):90-92
pubmed: 32891586
Cancers (Basel). 2022 Oct 05;14(19):
pubmed: 36230795
BMC Cancer. 2016 May 31;16:338
pubmed: 27246496
Cancers (Basel). 2021 Jan 05;13(1):
pubmed: 33466496
J Clin Oncol. 2023 Jan 1;41(1):117-127
pubmed: 35921605
Cancer Sci. 2008 Oct;99(10):2037-44
pubmed: 19016764
Cancers (Basel). 2021 Sep 03;13(17):
pubmed: 34503259
Liver Cancer. 2020 Dec;9(6):640-662
pubmed: 33442538
Front Oncol. 2023 May 17;13:1179431
pubmed: 37265792
Nat Rev Dis Primers. 2021 Jan 21;7(1):6
pubmed: 33479224
Am J Cancer Res. 2021 Oct 15;11(10):4956-4965
pubmed: 34765303
J Gastroenterol Hepatol. 2012 Apr;27(4):684-9
pubmed: 21916984
Cancer Biol Med. 2016 Dec;13(4):452-458
pubmed: 28154776